Appetite (Eating) Disorders Market - Forecast(2025 - 2031)

Appetite (Eating) Disorders Market Overview

Appetite (Eating) Disorders Market Size is forecast to reach $800 Million by 2030, at a CAGR of 5.4% during forecast period 2024-2030.Appetite (Eating) Disorders are a type of unleavened dough that is rolled flat and sliced into long strips or strings before being expanded or extruded. Appetite disorders are mental health disorders that involve severe problems with thoughts about food and eating behaviors. There are various Appetite Disorders, such as Anorexia Nervosa, Bulimia Nervosa, Rumination Disorder, Binge Eating Disorder, Purging Disorder, Food Intake Disorder, and Others. The rise in the prevalence of anorexia nervosa and bulimia nervosa disorders, growing research and development activities to develop advanced treatments for appetite disorders, and the increase in the incidences of suicides owing to psychiatric illnesses are the major factors contributing to the growth of the Appetite (Eating) Disorders Market for the forecast period 2022-2027.

Appetite (Eating) Disorders Market Report Coverage

The report: “Appetite (Eating) Disorders Market Forecast (2024-2030)", by Industry ARC covers an in-depth analysis of the following segments of the Appetite (Eating) Disorders Market.

Key Takeaways

• Geographically, North America held a dominant market share in the year 2021, owing to the trend of healthy food. The companies are offering innovative therapies for various eating disorders. A robust economy and a growing trend in in-home care facilities are driving demand for Appetite (Eating) Disorders Market in this region.

• The increasing prevalence of psychiatric illnesses is driving the growth of the Appetite (Eating) Disorders Market. However, the lack of awareness about appetite disorders is expected to hinder the growth of the target market to a certain extent.

• A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Appetite (Eating) Disorders Market Report.

Appetite (Eating) Disorders Market: Market Share (%) by Region, 2021

For more details on this report - Request for Sample

Appetite (Eating) Disorders Market Segmentation Analysis- By Type

Appetite (Eating) Disorders Market based on type can be further segmented into Anorexia Nervosa, Bulimia Nervosa, Rumination Disorder, Binge Eating Disorder, Purging Disorder, Food Intake Disorder, and Others. Anorexia Nervosa held a dominant market share in the year 2021. Anorexia nervosa is an eating disorder that results in severe weight loss and patients with anorexia nervosa are preoccupied with calorie intake and weight. The key players are focusing on developing a quality treatment for anorexia nervosa disorders.

However, Bulimia Nervosa is estimated to be the fastest-growing, with a CAGR of 5.8% over the forecast period of 2022-2027. This is owing to the growing prevalence of Bulimia Nervosa disorders and the rise in the availability of treatments for Bulimia Nervosa disorders in emerging countries.

Appetite (Eating) Disorders Market Segmentation Analysis- By End Use

Appetite (Eating) Disorders Market based on the End-Use can be further segmented into Hospitals, Specialty Clinics, and Others. The Hospitals segment held a dominant market share in the year 2021. The rise in the prevalence of psychiatric illnesses across the world and the growing availability of sophisticated professionals for treating eating disorders in hospitals are the major factors contributing to the growth of the Appetite (Eating) Disorders Market.

However, the Specialty Clinics segment is estimated to be the fastest-growing, with a CAGR of 6.2% over the forecast period of 2022-2027. Specialty clinics are providing outpatient clinic needs with cognitive-behavioral techniques that are specific for anorexia nervosa and bulimia nervosa disorders. As a result, the market for Appetite (Eating) Disorders is expected to grow throughout the forecast period. 

Appetite (Eating) Disorders Market Segmentation Analysis- By Geography

The Appetite (Eating) Disorders Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 34% in the year 2021. The rise in the prevalence of eating disorders is driving the growth of the market. Key manufacturers are leading the Appetite Disorders market in this region with innovative treatment developments and expansions.

Furthermore, Asia-Pacific is estimated to grow with the fastest CAGR over the forecast period 2022-2027. Consumers in this region have shown a willingness to spend more on their mental health. Some of the primary variables that are anticipated to enhance the demand for the Appetite (Eating) Disorders Market in this region are the growing availability of sophisticated professionals and an increase in the number of suicides owing to mental disorders.

Appetite (Eating) Disorders Market Drivers

The Increasing Prevalence of Anorexia Nervosa is a Key Factor in Market Growth.

Around 1.1% to 4.2% of the female population in the United States have bulimia nervosa and 0.5% to 3.7% of the female population in the country are suffering from anorexia nervosa. Approximately 1 million men and 7 million women are suffering from appetite disorders. Women are more prone to anorexia nervosa disorders than men. The key players are focusing on developing nutritional and functional therapies for anorexia nervosa disorders, which is one of the major factors driving the growth of the Appetite (Eating) Disorders Market.

The Rise in Psychiatric Illnesses is Propelling the Market Growth.

According to the World Health Organization (WHO), around 20% of adolescents and children across the world have mental health conditions, with suicide the second leading cause of death among the population below 29 years old. Appetite disorders co-occur with other psychiatric disorders, such as obsessive-compulsive disorder, mood and anxiety disorders, and alcohol and drug abuse problems. This rise in the prevalence of psychiatric illnesses is further propelling the growth of the Appetite (Eating) Disorders Market.

Appetite (Eating) Disorders Market Challenges

Lack of Awareness about the Appetite Disorders is Hampering the Growth of the Appetite (Eating) Disorders Market.

According to the National Eating Disorders Association 2020 Statistics, 60% of the patients make a full recovery in the United States. However, only 1 in 10 people with an eating disorder are seeking and receiving treatment for their disorders. Moreover, less than 43.6% of the people with binge eating disorders are receiving treatment in the United States. This lack of awareness about appetite disorders is one of the major factors that is said to reduce the growth of the Appetite (Eating) Disorders Market.

Appetite (Eating) Disorders Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Appetite (Eating) Disorders Market. The top 10- Appetite (Eating) Disorders Market companies are-

1.  Bausch & Lomb Incorporated
2. Somerset Therapeutics, LLC
3. Equip
4. Teva Pharmaceuticals Industries Ltd
5. Mylan N.V.
6. Pfizer Inc.
7. Amneal Pharmaceutical LLC
8. Sun Pharmaceutical Industries Ltd
9. Moriah Behavioral Health
10. Eli Lilly and Company

Recent Developments

• In April 2022, Moriah Behavioral Health opened its Dutch Valley home, which provides eating disorder treatment for adult females. It provides a comprehensive healthcare system for the treatment of anxiety disorders and eating disorders. The provides a full continuum of care for adolescent females struggling with eating disorders.

• In October 2021, Within Health company launched the first comprehensive treatment solution that is designed specifically for people suffering from various eating disorders. These solutions are designed to interrupt the progression of eating disorders and support long-term recovery. These solutions are targeted to benefit patients from receiving intensive clinical care anytime and in their homes.

• In October 2021, Equip company expanded into Colorado, Georgia, and Illinois. The expansion is targeted to ensure that every family has access to eating disorder treatment that works. The company has also closed a $13 million Series A funding round that is aimed at geographic expansion.

Key Market Players:

The Top 5 companies in the Appetite (Eating) Disorders Market are:

1. Teva Pharmaceuticals Industries Ltd
2. Eli Lilly and Company
3. Moriah Behavioral Health
4. Endo International Plc
5. QPS Holdings LL